Topical Statin Therapy in Wound Healing: A Systematic Review of Therapeutic Outcomes
Wound Repair and Regeneration · 2026-05 · 34 (3)
DOI: 10.1111/wrr.70181 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Wound Repair and Regeneration, online erschienen am 11.06.2026. Verfasst von Scott Stratman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Wound Healing, Wounds and Injuries. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Themen: Wundversorgung
Abstract (Originalsprache)
This systematic review evaluates the therapeutic potential of topical statin therapy in cutaneous wound healing across in vitro and in vivo animal and human studies. A PRIMSA‐guided PubMed search identified 31 eligible studies evaluating simvastatin, atorvastatin, pravastatin, rosuvastatin, or mevastatin formulated a creams, ointments, hydrogels, nanoemulgels, liposomal gels, nanosponges, films, and advanced dressing for diabetic, excisional, burn, infected, pressure, vascular, and postoperative wounds. Across models, topical statins consistently accelerated wound closure and improved histological quality through convergent mechanisms, including enhanced angiogenesis and lymphoangiogenesis, promotion of re‐epithelialization, modulation of collagen deposition and extracellular matrix remodelling, and attenuation of pro‐inflammatory and infectious burden. Mechanistic studies demonstrated activation of intracellular signalling pathways, upregulation of vascular endothelial growth factor and CD31, macrophage polarization, restoration of epidermal growth factor receptor signalling via caveolin‐1 and glucocorticoid receptor modulation, and context‐dependent regulation of collagen I/III and myofibroblast activity. Clinical data, although limited, showed some initial promise in pressure ulcers and laparotomy wound healing. Safety profiles were generally favorable, with xerosis and increased transepidermal water loss reported only at higher simvastatin concentrations. Overall, topical statins represent a promising, mechanistically rational adjunct for wound management; however, heterogeneity in wound types, formulations, dosing, and comparators, together with sparse, small clinical trials, underscores the need for rigorously designed human studies to define optimal indication, concentrations, and delivery systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Caroline Campbell Dermatology, Napa Valley, California, USA.
ORCID-Profile: Scott Stratman
Zitieren
APA
Stratman, S., Campbell, C., & He, H. (2026). Topical Statin Therapy in Wound Healing: A Systematic Review of Therapeutic Outcomes. Wound Repair and Regeneration, 34(3). https://doi.org/10.1111/wrr.70181
Vancouver
Stratman S, Campbell C, He H. Topical Statin Therapy in Wound Healing: A Systematic Review of Therapeutic Outcomes. Wound Repair and Regeneration. 2026;34(3). doi:10.1111/wrr.70181
BibTeX
@article{Stratman2026,
author = {Stratman, Scott and Campbell, Caroline and He, Helen},
title = {Topical Statin Therapy in Wound Healing: A Systematic Review of Therapeutic Outcomes},
journal = {Wound Repair and Regeneration},
year = {2026},
volume = {34},
number = {3},
doi = {10.1111/wrr.70181}
}
EUVIMED